Navigation Links
Sorbent Therapeutics Initiates Phase 2b Clinical Trial of CLP-1001 for Treatment of Signs and Symptoms of Fluid Overload in Patients with Heart Failure
Date:4/11/2013

SUNNYVALE, Calif., April 11, 2013 /PRNewswire/ -- Sorbent Therapeutics, Inc., a biopharmaceutical company developing therapies for cardiovascular and renal diseases, today announced that patient dosing has commenced in its Phase 2b clinical trial of CLP-1001.  This trial, known as STEPWISE (a randomized, double-blind, multi-center STudy comparing cross-linkEd Polyelectrolyte (CLP) WIth placebo in HF SubjEcts), is designed to evaluate the safety and efficacy of CLP-1001 in addressing signs and symptoms of fluid overload in patients with congestive heart failure (HF).  CLP-1001 is a novel, non-absorbed oral polymer that acts by binding to and removing excess sodium and fluid in the GI tract independently of the kidneys.

"The objective of the STEPWISE trial is to further understand the magnitude of the effect of CLP-1001 on key measures and clinical endpoints of heart failure-induced congestion compared to current standard of care," said Howard C. Dittrich , M.D., F.A.C.C., Chief Medical Officer of Sorbent.  "Fluid overload in heart failure patients contributes importantly to hospitalizations -- including re-hospitalizations -- slows in-patient recovery, and results in poor quality of life and physical limitations.  Based on the positive clinical benefits observed in our Phase 2a clinical trial, we look forward to advancing CLP-1001 through late-stage registration studies."   

STEPWISE is a double-blind, randomized, placebo-controlled, multicenter, study designed to evaluate CLP-1001 in patients with heart failure.  Approximately 250 patients on stable, optimized, guideline heart failure therapy that have signs and symptoms of current fluid overload after a recent HF-related hospitalization will be randomized to receive 15 grams of CLP-1001 or placebo.  The primary objective of this trial is to assess the change from baseline to eight weeks across sever
'/>"/>

SOURCE Sorbent Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Sorbent Therapeutics CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study
2. Sorbent Therapeutics Presents CLP1001 Phase 2a Study Results at the 16th Annual Meeting of the Heart Failure Society of America
3. Sorbent Therapeutics Appoints Jason Levin Chief Business Officer
4. CytoSorbents Receives Approximately $400,000 in Non-Dilutive Capital from the Sale of Net Operating Loss Carryovers
5. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
6. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
8. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
9. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
10. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
11. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Laboratories, Inc. (NASDAQ: IDXX ) today reported ... 11% versus the prior year period to $390 million. ... of 2014 versus the prior year period was 9%, ... . Earnings per diluted share ("EPS") for the quarter ... year period to $1.10."In the second quarter, we continued ...
(Date:7/25/2014)... , July 25, 2014  Semler Scientific, ... emerging medical risk assessment company that develops patented ... and evaluating chronic diseases, today reported financial results ... June 30, 2014. "The second ... Semler," said Doug Murphy-Chutorian , M.D., chief ...
(Date:7/25/2014)... NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE ... ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION ... (NYSE: ABBV ) today announced financial results for ... "This was another very strong quarter for AbbVie, as we ... and announced plans to merge with Shire, a strategic action ...
Breaking Medicine Technology:IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21IDEXX Laboratories Announces Second Quarter Results 22IDEXX Laboratories Announces Second Quarter Results 23IDEXX Laboratories Announces Second Quarter Results 24IDEXX Laboratories Announces Second Quarter Results 25IDEXX Laboratories Announces Second Quarter Results 26IDEXX Laboratories Announces Second Quarter Results 27IDEXX Laboratories Announces Second Quarter Results 28IDEXX Laboratories Announces Second Quarter Results 29IDEXX Laboratories Announces Second Quarter Results 30IDEXX Laboratories Announces Second Quarter Results 31IDEXX Laboratories Announces Second Quarter Results 32IDEXX Laboratories Announces Second Quarter Results 33IDEXX Laboratories Announces Second Quarter Results 34Semler Reports Second Quarter 2014 Financial Results 2Semler Reports Second Quarter 2014 Financial Results 3
(Date:7/26/2014)... As the category creator and world ... Xoçai is to transform and improve ... chocolate products. One such unique element is XoVita™, ... and blueberries, an ingredient combination exclusive to Xoçai. ... in all of Xoçai products and provides a ...
(Date:7/25/2014)... 2014 PersonalInjurySolicitorsIreland, a legal claims ... people who have suffered from a variety of ... their new company, and a website, http://www.PersonalInjurySolicitorsIreland.com ... website explained, http://www.personalinjurysolicitorsireland.com/personal-injury-claims , the law firm ... the company is always on the client, and ...
(Date:7/25/2014)... In recent years, men have become more ... the symptoms associated with age-related testosterone decline. Amid concerns about ... new case study from Renew Man helps to ... using bioidentical hormones. , The case study centers around ... found himself beginning to feel the effects of age-related hormonal ...
(Date:7/25/2014)... York (PRWEB) July 25, 2014 A ... summary judgment in two DePuy Pinnacle hip lawsuits ( ... way for the claims to go before a jury ... an opinion rendered on July 18th, U.S. District Judge ... that the two Plaintiffs’ claims may proceed to trial ...
(Date:7/25/2014)... 2014 Ticket Down announces ... for the Guinness International Champions Cup match between international ... Soldier Field on Sunday, July 27th. This ... promo/coupon/offer code SOCCER-2014 for added savings. , 2014 is ... soccer fans in North America. Countless international soccer teams ...
Breaking Medicine News(10 mins):Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 2Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 3Health News:Xocai-Asia Japanese Distributors in Hachioji, Japan Sanction Local Single-Source-Chocolate Investigative Report: MXI-Corp-Asia Discloses Direct-Sales Compensation Plan 4Health News:PersonalInjurySolicitorsIreland.com Announces the Launch of their New Company and Website 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 2Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 3Health News:First Federal DePuy Pinnacle Hip Lawsuits Headed for Trial, As Judge Denies Defense Motions For Dismissal, Summary Judgment, Bernstein Liebhard LLP Reports 4Health News:Liverpool FC vs. Olympiacos FC Tickets Soldier Field: Ticket Down Slashes Ticket Prices for Guinness International Champions Cup in Chicago on Sunday, July 27th 2
... The following was,issued by the National Community ... new Medicaid generic,prescription drug reimbursement rule and need ... his power to make sure the legislative fix ... rule, scheduled to be,fully implemented in early 2008, ...
... top-rated, portable filter purifier; Two ozone generators deemed ... its latest tests of,air purifiers, Consumer Reports, experts concluded ... the most effective at removing dust,and smoke. And, unlike ... irritating ozone., While ozone in the upper atmosphere ...
... Inc.,(Nasdaq: VARI ) today announced that it ... owned company based in Burlington, Wisconsin, for,approximately $11 ... to certain,net asset adjustments. The transaction also includes ... years, depending on future,milestones and financial performance. Those ...
... The International SPA,Association Monday issued a recall ... major outside research firm, citing a number of ... recall includes,all information contained in the ISPA 2007 ... and the Spa & Institut Beyond Beauty,Paris 2007 ...
... Children as young as 7 show signs of cardiovascular risk factors, ... let your children grow up to be fat -- or even ... point in their body mass index (BMI, a ratio of weight ... with childhood, adolescence and adulthood. , But the earlier a child ...
... ... Third- World Farmers, ST. LOUIS, Nov. 5 ... recognized and distinguished scientists,economists and thought leaders discuss the use of ... safety, benefits to,the environment, and contributions to the lives of third-world ...
Cached Medicine News:Health News:Pharmacists Press Conference Urging Senate Majority Leader Harry Reid to Fix Flawed Medicaid Drug Reimbursement Rule 2Health News:Consumer Reports Finds Filter-Based Air Purifiers are Better Choice for Consumers 2Health News:Consumer Reports Finds Filter-Based Air Purifiers are Better Choice for Consumers 3Health News:Consumer Reports Finds Filter-Based Air Purifiers are Better Choice for Consumers 4Health News:Varian, Inc. Acquires Analogix Business 2Health News:ISPA Issues Immediate Recall of 2007 Global Consumer Studies 2Health News:Early Weight Gain Can Mean Heart Trouble Later in Life 2Health News:Early Weight Gain Can Mean Heart Trouble Later in Life 3Health News:Fourteen Global Experts Comment on the Safety and Use of Genetically Modified Food Crops 2Health News:Fourteen Global Experts Comment on the Safety and Use of Genetically Modified Food Crops 3Health News:Fourteen Global Experts Comment on the Safety and Use of Genetically Modified Food Crops 4
0-3.5 LPM Oxygen Flowmeter 1/8" NPT Female inlet...
(1-15 LPM), 50 psi, 1/ 8" NPT female back inlet...
... style oxygen flowmeters., ,Options: ... suffix S to model number. ... Color-Code, add suffix C to ... For Double Flowmeters with Power ...
Value-Line oxygen flowmeters. ,Options: , For security chain, add suffix S to model number. Example: FMQ107S. , For Canadian Color-Code, add suffix FMQ104C. , For Double Flowmeters with Power Take-Of...
Medicine Products: